Agewall Stefan Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Astra Zeneca : Platelet inhibition
Bassand Jean-Pierre Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Glaxo Smith Kline : fondaparinux - Lilly : prasugrel
- Astra Zeneca : ticagrelor
Bax Jeroen Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Heart.org : Education - Astra Zeneca : Farma
- Servier : Farma
- Philips : Imaging
- GE Healthcare : Imaging
- Lantheus : Imaging
- Boston Scientific : Pacing
- Medtronic : Pacing
- St Jude Medical : Pacing
- Biotronik : Pacing
- Impulse Dynamics : Pacing
D - Research funding (departmental or institutional). - Servier : Farma - Edwards Lifesciences : Heart Valves
- GE Healthcare : Imaging
- Lantheus : Imaging
- Boston Scientific : Pacing
- Medtronic : Pacing
- St Jude Medical : Pacing
Guidelines on ACS-NSTE (TF21) - Task Force Members and Additional Contributors
Expert Relationship with Industry
Type of relationship with industry Financial declaration
Bax Jeroen Yes - Biotronik : Pacing
Boersma Eric Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Medtronic : coronary artery disease
Bueno Hector Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Bayer Healthcare : Aspirin - Merck, Schering Plough : None
- Daiichi Sankyo : Prasugrel
- Eli Lilly : Prasugrel
- Astra Zeneca : Ticagrelor
Caso Pio Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Consorzio formazione medica : lessons C - Receipt of royalties for intellectual property. - piccin nuova libraria spa : book
Dudek Dariusz Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Boehringer-Ingelheim : speaker fee, advisory boards, investigator. - Boston Scientific : speaker fee, advisory boards, investigator.
- Eli Lilly : speaker fee, advisory boards, investigator.
- Pfizer : speaker fee, advisory boards, investigator.
- Sanofi Aventis : speaker fee, advisory boards, investigator.
- Siemens Healthcare : speaker fee, advisory boards, investigator.
- GlaxoSmithKline : speaker fee, advisory boards, investigator.
- Bayer Healthcare : speaker fee, advisory boards, investigator.
- Cook Medical : speaker fee, advisory boards, investigator.
- Medicines Company : speaker fee, advisory boards, investigator.
- Nycomed : speaker fee, advisory boards, investigator.
- Bristol Myers Squibb : speaker fee, advisory boards, investigator.
- MSD : speaker fee, advisory boards, investigator.
Guidelines on ACS-NSTE (TF21) - Task Force Members and Additional Contributors
Expert Relationship with Industry
Type of relationship with industry Financial declaration
Dudek Dariusz Yes - Balton : speaker fee, advisory boards, investigator.
- Cordis : speaker fee, advisory boards, investigator.
- Biotronic : speaker fee, advisory boards, investigator.
- Solvay : speaker fee, advisory boards, investigator.
- BBraun : speaker fee, advisory boards, investigator.
- EuroCor : speaker fee, advisory boards, investigator.
- INvatec : speaker fee, advisory boards, investigator.
- Medtor : speaker fee, advisory boards, investigator.
- Promed : speaker fee, advisory boards, investigator.
- Therumo : speaker fee, advisory boards, investigator.
- Tyco : speaker fee, advisory boards, investigator.
E - Research funding (personal). - Abbott : speaker fee, advisory boards, investigator. - Adamed : speaker fee, advisory boards, investigator.
- Astra Zeneca : speaker fee, advisory boards, investigator.
- Boehringer-Ingelheim : speaker fee, advisory boards, investigator.
- Boston Scientific : speaker fee, advisory boards, investigator.
- Eli Lilly : speaker fee, advisory boards, investigator.
- Medtronic : speaker fee, advisory boards, investigator.
- Pfizer : speaker fee, advisory boards, investigator.
- Biotronik : speaker fee, advisory boards, investigator.
- Terumo Inc : speaker fee, advisory boards, investigator.
- Sanofi Aventis : speaker fee, advisory boards, investigator.
- Siemens Healthcare : speaker fee, advisory boards, investigator.
- GlaxoSmithKline : speaker fee, advisory boards, investigator.
Guidelines on ACS-NSTE (TF21) - Task Force Members and Additional Contributors
Expert Relationship with Industry
Type of relationship with industry Financial declaration
Dudek Dariusz Yes - Bayer Healthcare : speaker fee, advisory boards, investigator.
- Cook Medical : speaker fee, advisory boards, investigator.
- Nycomed : speaker fee, advisory boards, investigator.
- MSD : speaker fee, advisory boards, investigator.
- Balton : speaker fee, advisory boards, investigator.
- Cordis : speaker fee, advisory boards, investigator.
- Solvay : speaker fee, advisory boards, investigator.
- BBraun : speaker fee, advisory boards, investigator.
- EuroCor : speaker fee, advisory boards, investigator.
- INvatec : speaker fee, advisory boards, investigator.
- Promed : speaker fee, advisory boards, investigator.
- Tyco : speaker fee, advisory boards, investigator.
- Biomatrix : speaker fee, advisory boards, investigator.
- Mediciine Company : speaker fee, advisory boards, investigator.
Gielen Stephan Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Genzyme : Lecture on genetic cardiac diseases incl. M. Fabry, 1000 € honorarium - Astra zeneca, boheringer, menarini : Product-independent cardiology case workshop twice a year, honorarium 1.100 € per event
Hamm Christian Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Merck : drugs - Pfizer : drugs
- Sanofi-Aventis : drugs
- The Medicines Company : drugs
- Menarini : drugs
- Daiichi-Sankyo : drugs
- Berlin Chemie AG : drugs
Guidelines on ACS-NSTE (TF21) - Task Force Members and Additional Contributors
Expert Relationship with Industry
Type of relationship with industry Financial declaration
Hamm Christian Yes - Heart.org : drugs
- Boehringer Ingelheim - Ingelheim; Daiichi-Sankyo/Eli Lilly; Nycomed Pharma : drugs
- Takeda Pharmaceuticals : drugs
- Glaxo Smith Kline : drugs
- Astra Zeneca, Bayer AG, Boehringer-Ingelheim, Daiichi-Sankyo, MSD, Novartis, Pfizer, Sanofi-Aventis, Servier : drugs
- BRAHMS GmbH : markers
- Siemens Healthcare : MRI
- Boston Scientific : PCI
- Cordis and Medtronic : PCI
Huber Kurt Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Pfizer - speakers fees : atorvastatin - The Medicines Company - speakers fees : bivalirudin; cangrelor
- BRAHMS GmbH - speakers fees : copeptin assay
- Boehringer Ingelheim - speakres fees; advisory board fees (dabigatran) : dabigatran
- Boston Scientific - speakres fees : none
- Biotronik - speakers fees : none
- Eli Lilly Lilly/Daiichi Sankyo - speakers fees; advisory board fees (prasugrel) : prasugrel; abciximab
- Bayer - speaker fees; advisory board fees (rivaroxaban) : rivaroxaban
- Astra Zeneca - speakers fees; advisory board fees (ticagrelor) : ticagrelor; rosuvastatin
Ohman E Magnus Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Liposcience : Diagnostic tests - WebMD : Online health information provider
- Astra Zeneca : Pharmaceuticals
- Boehringer-Ingelheim : Pharmaceuticals
- The Medicines Company : Pharmaceuticals
Guidelines on ACS-NSTE (TF21) - Task Force Members and Additional Contributors
Expert Relationship with Industry
Type of relationship with industry Financial declaration
Ohman E Magnus Yes - Sanofi Aventis : Pharmaceuticals
- Bristol Myers Squibb : Pharmaceuticals
- Merck Sharp & Dohme : Pharmaceuticals
- Gilead Sciences : Pharmaceuticals
- Pozen, Inc. : Pharmaceuticals
B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Daiichi Sankyo : Pharmaceuticals - Eli Lilly : Pharmaceuticals
D - Research funding (departmental or institutional). - Maquet : Medical technology/products - Daiichi Sankyo : Pharmaceuticals
- Eli Lilly : Pharmaceuticals
Petrie Mark Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Roche : diabetes - GSK : diabetes
- Astellas : diabetes
- Servier : heart failure
Sonntag Frank Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Servier : CAD - Sanofii-Aventis : CAD
- Bayer Healthcare : CAD
- Merck Sharp & Dome : CAD
- Boehringer Ingelheim - : CAD
- Astra Zeneca : CAD,Plateletaggregationinhibitor
Sousa Uva Miguel Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Medtronic : TAVI
Guidelines on ACS-NSTE (TF21) - Task Force Members and Additional Contributors
Expert Relationship with Industry
Type of relationship with industry Financial declaration
Sousa Uva Miguel Yes B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Lilly : Antiplatelet agent
Storey Robert Frederick Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - The Medicines Company : Cangrelor - Sanofi Aventis : Clopidogrel
- Bristol Myers Squibb : Clopidogrel
- Novartis : Elinogrel
- GlaxoSmithKline : Fondaparinux
- Eli Lilly Lilly/Daiichi Sankyo - speakers fees; advisory board fees (prasugrel) : Prasugrel
- Astra Zeneca : Ticagrelor
- Merck : Vorapaxar
B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Astra Zeneca : Ticagrelor - Accumetrics : VerifyNow
D - Research funding (departmental or institutional). - Daiichi Sankyo : Prasugrel - Eli Lilly : Prasugrel
- Astra Zeneca : Ticagrelor
- Merck : Vorapaxar
Wijns William Yes B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Boston Scientific : device - Edwards Lifesciences : device
- Terumo Inc : device
- Cordis : device
- Orbus Neich : device
- Astra Zeneca : drug
Guidelines on ACS-NSTE (TF21) - Task Force Members and Additional Contributors
Expert Relationship with Industry
Type of relationship with industry Financial declaration
Wijns William Yes - Eli Lilly : drug
- GlaxoSmithKline : drug
- Bristol Myers Squibb : drug
D - Research funding (departmental or institutional). - Cardio3 Biosciences : cell therapy - Boston Scientific : device
- Medtronic : device
- St Jude Medical : device
- Abbott Laboratories : device
- Biotronic : device
- Therabel : drug
- Ablynx : nano antibodies
Zahger Doron Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Sanofi Aventis : Dronedarone - Pfizer : lipitor
- Eli Lilly : prasugrel
- Astra zeneca, boheringer, menarini : Ticagrelor
Guidelines on ACS-NSTE (TF21) - TF Members and Additional Contributors
Expert Relationship with Industry
Type of relationship with industry Financial declaration
Achenbach Stephan Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Siemens Healthcare : CT - Servier : Imaging
- Guerbet : Imaging
D - Research funding (departmental or institutional). - Siemens Healthcare : Imaging - Bayer Healthcare : Imaging
Badimon Lina Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Astra Zeneca : cardiovascular - Menarini : cardiovascular
- Esteve : Cardiovascular
Bertrand Michel Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Lilly : Anticoagulants - Servier International : Antihypertensive drugs. Antiischemic drugs
Botker Hans Erik Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Astra Zeneca - speaker fee : Hyperlipidema, angina pectoris
Collet Jean-Philippe Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Bristol Myers Squibb : apixaban - Nycomed : aspirin
- Sanofi Aventis : clopidogrel
- Roche Diagnostics : hypersensitive troponin
- Astra Zeneca : prasugrel
- Eli Lilly : prasugrel
D - Research funding (departmental or institutional). - Sanofi-Aventis : clopidogrel - Cordis and Medtronic : platelet function testing
Crea Filippo Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Pfizer - speakers fees : Atorvastatin
Guidelines on ACS-NSTE (TF21) - Document Reviewers
Expert Relationship with Industry
Type of relationship with industry Financial declaration
Crea Filippo Yes - Boehringer Ingelheim-Advisory Board : Dabigatran
- GSK : Darapladip
- Sanofi Aventis - speaker fee : Prasugrel
- Astra Zeneca - speaker fee : Rosuvastatin
- Chiesi - speaker fees : Rosuvastatin
D - Research funding (departmental or institutional). - Pfizer : Atorvastatin - Sanofi Aventis : Prasugrel
- Chiesi - speaker fees : Rosuvastatin
Danchin Nicolas Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Servier : antianginal agents - The Medicines Company : Antithrombotic agents
- BMS/Pfizer : Antithrombotic agents
- Boehringer Ingelheim : Antithrombotic agents
- Daiichi Sankyo, Eli-Lilly : Antithrombotic agents
- Sanofi-Aventis : antithrombotic agents, antiarrhythmic agents
- Astra-Zeneca : Antithrombotic agents, statins
- Novo-Nordisk : Diabetes
- Pierre Fabre : Omega 3
D - Research funding (departmental or institutional). - Merck : Myocardial infarction - Sanofi-Aventis : Myocardial infarction
- The Medicines Company : Myocardial infarction
- GSK : Myocardial infarction
- Astra-Zeneca : Myocardial infarction
- Daiichi-Sankyo Eli Lilly : Myocardial infarction
Guidelines on ACS-NSTE (TF21) - Document Reviewers
Expert Relationship with Industry
Type of relationship with industry Financial declaration
Falk Erling No
Goudevenos John A No
Gulba Dietrich Cl Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - The Medicines Company : Bivalirudin - Boehringer-Ingelheim : Dabigatran, rt-PA, TNK-tPA
- Sanofi Aventis : Enoxaparin
- Daiichi Sankyo : Prasugrel
- Eli Lilly : Prasugrel, abciximab
- Bayer Healthcare : Rivaroxaban
- Astra Zeneca : Ticagrelor
Hambrecht Rainer Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Berlin Chemie : ranolazine B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - pohl boskamp : nitrates
Herrmann Joerg No
Kastrati Adnan Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Abbott - lecture fees : DES B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Astra Zeneca : Antiplatelet - Lilly : Antiplatelet
- Biosensors : DES
- Cordis : DES
- Biotronic : DES
Kjeldsen Keld Per No
Kristensen Steen Dalby Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Daiichi Sankyo : Antithrombotics - Eli Lilly : Antithrombotics
Guidelines on ACS-NSTE (TF21) - Document Reviewers
Expert Relationship with Industry
Type of relationship with industry Financial declaration
Kristensen Steen Dalby Yes - Merck : Antithrombotics
- The Medicines Company : Antithrombotics
- AstraZeneca : Antithrombotics
Lancellotti Patrizio Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - ,astra zeneca, boheringer, menarini : pradaxa, belsar, crestor B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Actelion : tracleer
Mehilli Julinda Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Daiichi Sankyo - speaker fee : Antithrombotic drugs - Abbott - lecture fees : Stents
D - Research funding (departmental or institutional). - Abbott : Unrestricted grant for clinical studies - Terumo : Unrestricted grant for clinical studies
Merkely Bela Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Abbott, Biotronik, Boston Sci, Medtronic, Sanofi-Aventis, Servier, St. Jude : CRT implantation, ICD programing, education program, dronaderone, ivabradineB - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Abbott, Johnson & Johnson, Medtronic, : Xience V stent, education program
Montalescot Gilles Yes
B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Astra Zeneca - consulting or lecture fees : xy - Bayer - consulting or lecture fees : xy
- Boehringer Ingelheim - consulting or lecture fees : xy
- Cardiovascular Research Foundation - consulting or lecture fees : xy
- Cleveland Clinic Research Foundation - consulting or lecture fees : xy
- Daiichi Sankyo - consulting or lecture fees : xy
- Duke Institute - consulting or lecture fees : xy
- Eli Lilly - consulting or lecture fees : xy
Guidelines on ACS-NSTE (TF21) - Document Reviewers
Expert Relationship with Industry
Type of relationship with industry Financial declaration
Montalescot Gilles Yes - Europa - consulting or lecture fees : xy
- Lead-Up - consulting or lecture fees : xy
- GSK - consulting or lecture fees : xy
- Institut de Cardiologie de Montreal - consulting or lecture fees : xy
- Menarini - consulting or lecture fees : xy
- Nanospheres - consulting or lecture fees : xy
- Novartis - consulting or lecture fees : xy
- Pfizer - consulting or lecture fees : xy
- Portola - consulting or lecture fees : xy
- Sanofi Aventis - consulting or lecture fees : xy
- The Medicines Company - consulting or lecture fees : xy
- TIMI study group - consulting or lecture fees : xy
D - Research funding (departmental or institutional). - Astra Zeneca : xy - BMS : xy
- Boston Scientific : xy
- Eli Lilly : xy
- Medtronic : xy
- Pfizer : xy
- Servier : xy
- Sanofi Aventis : xy
- Abbott Vascular : xy
- Cordis : xy
- Fédération Française de Cardiologie : xy
- Fondation de France : xy
Guidelines on ACS-NSTE (TF21) - Document Reviewers
Expert Relationship with Industry
Type of relationship with industry Financial declaration
Montalescot Gilles Yes - Guerbet Medical : xy
- INSERM : xy
- ITC Edison : xy
- Société Française de Cardiologie : xy
- Stago : xy
Neumann Franz Josef Yes
B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Boston Scientific : devices - Medtronic : devices
- Cordis : devices
- Biotronic : devices
- Astra Zeneca : drugs
- The Medicines Company : drugs
- Lilly : drugs
- Siemens Healthcare : equipment
D - Research funding (departmental or institutional). - Boston Scientific : devices - Cordis : devices
- Metronic : devices
- Lilly : drugs
Neyses Ludwig Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Servier - speaker fees; investigator fees : Ivabradine D - Research funding (departmental or institutional). - Johnson & Johnson : Diagnostic use of metabolomics
Perk Joep Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Astra Zeneca - speaker fees : None specific
Guidelines on ACS-NSTE (TF21) - Document Reviewers
Expert Relationship with Industry
Type of relationship with industry Financial declaration
Perk Joep Yes B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Astra Zeneca : None specific
Pfisterer Matthias No
Roffi Marco Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Eli Lilly Lilly/Daiichi Sankyo - speakers fees; advisory board fees (prasugrel) : Antiplatelet therapy D - Research funding (departmental or institutional). - Abbott : devices - Boston Scientific : devices
- Cordis and Medtronic : devices
- Biotronik : devices
Romeo Francesco No
Ruda Mikhail Ya No
Swahn Eva Yes
D - Research funding (departmental or institutional). - Schering-Plough : Phase III study (TRACER)
Tavares Aguiar Carlos Manuel
Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Merck Sharp & Dohme - speaker fees : Niacin/Laropiprant - Menarini - speaker fees : Olmesartan
- Servier - speaker fees; investigator fees : Perindopril/Indapamide, Ivabradine
- Lilly - consultancy fees : Prasugrel
- Bayer - speaker fees; advisory board fees (rivaroxaban) : Rivaroxaban, Nifedipine, Telmisartan, Aspirin
- Astra Zeneca - speaker fees : Rosuvastatin
- Boehringer Ingelheim - speaker fees : Telmisartan
- Bial Portela - speaker fees : Valsartan/Amlodipine
Valgimigli Marco Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - The Medicines Company : bivalirudin - Terumo : Interventional cardiology
Guidelines on ACS-NSTE (TF21) - Document Reviewers
Expert Relationship with Industry
Type of relationship with industry Financial declaration
Valgimigli Marco Yes - Abbott Laboratories : ngal
- Accumetrics : Platlet Function Assay
- Roche Pharma : PPAR alpha/gamma
- Medtronic : stent
- Abbott Vascular : stent
- Cordis : stent
- CID : stent
- Astra Zeneca - consulting or lecture fees : ticagrelor
- Chiesi Pharma : tirofiban
- Iroko Cardio : Tirofiban
D - Research funding (departmental or institutional). - Abbott Laboratories : ngal
Vrints Christian Joseph Marie
Yes
B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Bayer : pharma D - Research funding (departmental or institutional). - Abbott : interventional cardiology - Medtronic : pacing
Widimsky Petr Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Servier : Antiischemic agents - Astra Zeneca : Antithrombotic agents
- Bayer : Antithrombotic agents
- Boehringer-Ingelheim : Antithrombotic agents
- Daiichi Sankyo : Antithrombotic agents
- Eli Lilly : Antithrombotic agents
- The Medicines Company : Antithrombotic agents
Guidelines on ACS-NSTE (TF21) - Document Reviewers
Expert Relationship with Industry
Type of relationship with industry Financial declaration
Widimsky Petr Yes - Duke University : Antithrombotic agents
- Abbott : Stents
- Boston Scientific : Stents
- Medtronic : Stents
Guidelines on ACS-NSTE (TF21) - Document Reviewers
Expert Relationship with Industry
Type of relationship with industry Financial declaration
ESC Committee for Practice Guidelines 2010-2012
ExpertRelationship
with IndustryType of relationship with industry Financial declaration
A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesAuricchio Angelo
- Biologics Delivery Systems, Cordis Corporation a Johnson & Johnson company : Biological Therapy
- Philips : Cardiac Imaging
- Merck : Drugs
- Biotronik : Implantable Cardiac Electronic Device
- EBR Systems : Implantable Cardiac Electronic Device
- Impulse Dynamics : Implantable Cardiac Electronic Device
- Medtronic : Implantable Cardiac Electronic Device
- Sorin : Implantable Cardiac Electronic Device
- St. Jude Medical : Implantable Cardiac Electronic Device
- Abbott : Implantable Cardiac Electronic Device
A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesBaumgartner Helmut
- Actelion : Bosentan for PAH treatment in congenital heart disease
- AGA : Devices for catheter treatment of congenital heart defects
B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.
- Edwards Lifesciences : transcatheter valve implantation
A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesBax Jeroen
- Heart.org : Education
- Servier : Farma
- Astra Zeneca : Farma
- GE Healthcare : Imaging
- Lantheus : Imaging
- Philips : Imaging
- St Jude Medical : Pacing
ESC Committee for Practice Guidelines 2010-2012
ExpertRelationship
with IndustryType of relationship with industry Financial declaration
- Medtronic : Pacing
- Impulse Dynamics : Pacing
- Biotronik : Pacing
- Boston Scientific : Pacing
D - Research funding (departmental or institutional).YesBax Jeroen
- Servier : Farma
- Edwards Lifesciences : Heart Valves
- Lantheus : Imaging
- GE Healthcare : Imaging
- Boston Scientific : Pacing
- Medtronic : Pacing
- St Jude Medical : Pacing
- Biotronik : Pacing
A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesCeconi Claudio
- Servier : Pharmaceutical
A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesDeaton M Christi
- St Jude Ltd : Cath lab - speaker X 1
- Daiichi Sankyo : consultant for patient adherence 2009-10
- Eli Lilly : consultant for patient adherence 2009-10
D - Research funding (departmental or institutional).
- Novo Nordisk : medicines for diabetes
A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesFagard Robert
- Servier : perindopril; support for organisation of scientific meeting
A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesFunck-Brentano Christian
- Pierre-Fabre : Cardiac Safety of non-cardiovasclar products
ESC Committee for Practice Guidelines 2010-2012
ExpertRelationship
with IndustryType of relationship with industry Financial declaration
- Servier : Cardiac safety of non-cardiovascular drugs under development or on the market. Design of phase I/II trials.
- Johnson & Johnson : Cardiac safety of non-cardiovascular drugs under development or on the market. Design of phase I/II trials.
- Sigma-Tau (Italy) : Cardiac Saftey of an antimalarial drug
- Santhera (CH) : Cardiac Saftey of an antimalarial drug
- MMV (CH) : Cardiac Saftey of an antimalarial drug
- TROPHOS : DSMB for an investigational drug in Amyotrophic Lateral Sclerosis – Cardiac safety
- CEPHALON : DSMB in an oncology phase IIb trial
- Jansen-Cilag : Proton-pump inhibitors and drug interactions, including Clopidogrel
D - Research funding (departmental or institutional).YesFunck-Brentano Christian
- Jansen-Cilag : Proton-pump inhibitors and drug interactions with Clopidogrel
A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesHasdai David
- Sanofi Aventis : Enoxaparin
D - Research funding (departmental or institutional).YesHoes Arno
- Bayer Healthcare : unresctricted grant for diagnostic kits in suspected cardiovascualar disease
- Abbott Laboratories : unresctricted grant for diagnostic kits in suspected cardiovascualar disease
- Roche : unresctricted grant for diagnostic kits in suspected heart failure and acute coronary syndrome
A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesKnuuti Juhani
- Lantheus Inc : Imaging tracers
D - Research funding (departmental or institutional).
- Bayer : Development of imaging agents
- GE Healthcare : Development of imaging agents
- Lantheus : Development of imaging agents
- Novartis : Development of imaging agents
- Roche : Drugs for brain diseases
A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesKolh Philippe H
ESC Committee for Practice Guidelines 2010-2012
ExpertRelationship
with IndustryType of relationship with industry Financial declaration
- Merck Sharp & Dohme : Antiarrhythmic agents
- Bristol Myers Squibb : Antiplatelet agents
- Astra Zeneca : Antiplatelet agents
- Regado Biosciences : Antithrombotic agents
- Abbott - lecture fees : coronary stents
B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesKolh Philippe H
- Merck Sharp & Dohme : Antistaphylococcic vaccine
D - Research funding (departmental or institutional).
- Edwards Lifesciences : Cardiac valves
- Medtronic : Cardiac valves
- St Jude Medical : Cardiac valves
- Siemens Healthcare : Imaging
- Johnson & Johnson : Thoracoscopic devices
A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesMcDonagh Theresa
- Vifor International : Ferrinject
B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.
- Servier - speaker fee : Ivabridine
D - Research funding (departmental or institutional).
- Biotronik - Clinical Trial : CRT
D - Research funding (departmental or institutional).YesPoldermans Don
- Maquette : Balloon pump device
- Merck : drugs
- Novartis : drugs
- Baxter : drugs
- Medtronic : Reveal device
ESC Committee for Practice Guidelines 2010-2012
ExpertRelationship
with IndustryType of relationship with industry Financial declaration
A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesPopescu Bogdan Alexandru
- GE Healthcare : Imaging
A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesReiner Zeljko
- Bayer Healthcare : anticoagulants
- Abbott - lecture fees : antilipemics
- Astra Zeneca : antilipemics
- Merck Sharp & Dohme : antilipemics
- Pfizer : antilipemics
A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesSechtem Udo
- Boehringer Ingelheim : Anticoagulation
- Daiichi Sankyo : Antiplatelet therapy
- Novartis : Drugs
- General Electric : Imaging
- Siemens Healthcare : Imaging
B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.
- Novartis : Imaging devices
- Johnson & Johnson : Stents
D - Research funding (departmental or institutional).YesSirnes Per Anton
- Bayer : clinical studies atrial fibrillation investigator fee
- Johnson & Johnson : inestigator fee, ckinical study, atrial fibrillation
- MSD : investgator fee clinical studies hyperlipidemia, SCAD
- Glaxo Smith Kline : investigator fee, clinical study , SCAD
- Servier : investigator fee, clinical study, coronary artery disease
- Jansen-Cilag : investigator fee, clinical study, diabetes CVD
- Boehringer Ingelheim : investigator fee, clinicla study, AF
ESC Committee for Practice Guidelines 2010-2012
ExpertRelationship
with IndustryType of relationship with industry Financial declaration
A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesTorbicki Adam
- Boehringer-Ingelheim : anticoagulation
- Sanofi Aventis : anticoagulation
- Pfizer : anticoagulation, pulmonary hypertension
- Lilly : pulmonary hypertension
- Actelion : pulmonary hypertension
- Bayer Healthcare : pulmonary hypertension, anticoagulation
A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesVahanian Alec
- Boehringer Ingelheim : Valve prostheses
- Siemens Healthcare : Valve prostheses
- Valtech : Valve prostheses
- Edwards Lifesciences : Valve prostheses
- Abbott : Valve prostheses
- Medtronic - Advisory Board : Valve prostheses
A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesWindecker Stephan
- Astra Zeneca : Antiplatelet drug
- Eli Lilly : Antiplatelet drug
- Abbott : Stent
- Biosensors : Stent
- Biotronik : Stent
- Boston Scientific : Stent
- Cordis : Stent
- Medtronic : Stent
D - Research funding (departmental or institutional).
- Medtronic : Stent
ESC Committee for Practice Guidelines 2010-2012
ExpertRelationship
with IndustryType of relationship with industry Financial declaration
- Abbott : Stent
- Biosensors : Stent
- Cordis : Stent
This table represents the relevant relationships of the above experts with Industry and other entities that were reported to us at the time of publication of the guidelines.